Package 62135-613-30

{"route": ["ORAL"], "spl_id": "459d28fe-0458-21de-e063-6394a90a6e87", "openfda": {"upc": ["0362135613303", "0362135614300", "0362135613907", "0362135614904"], "unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["e59f15d0-c32a-4848-bdd5-fc2542e561c0"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62135-613-30)", "package_ndc": "62135-613-30", "marketing_start_date": "20230621"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (62135-613-90)", "package_ndc": "62135-613-90", "marketing_start_date": "20230621"}], "brand_name": "Valacyclovir", "product_id": "62135-613_459d28fe-0458-21de-e063-6394a90a6e87", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "62135-613", "generic_name": "Valacyclovir", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20181001", "listing_expiration_date": "20261231"}